CHMP greenlights Novartis Zolgensma
The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
New resource models human metabolism
Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Novacyt inks contract on Covid-19 diagnostics
Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA gets Lilly milestone for Alzheimers candidate
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Experts discuss link between sepsis and Covid-19
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries AG establishes production of recombinant collagen
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
BioNTech SEs COVID-19 vaccine attracts investment
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTechd mRNA vaccine BNT162.
Commission relaunches circular economy action plan
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Roche unravel biomarker for checkpoint blockade
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
Nutrition influences the course of MS
New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).